Why the study?
Do septal E/e' ratio ≥11 and AF duration >90 days predict AF recurrence at 3 months in patients with symptomatic persistent AF and LA enlargement undergoing cardioversion?
Do septal E/e' ratio ≥11 and AF duration >90 days predict AF recurrence at 3 months in patients with symptomatic persistent AF and LA enlargement undergoing cardioversion?
Septal E/e' ratio ≥11 and AF duration >90 days are useful predictors of AF recurrence at 3 months after cardioversion in patients with persistent AF and LA enlargement.
May aid post-cardioversion risk stratification in persistent AF; leaves open confirmation in prospective cohorts.
In this population with symptomatic persistent AF and LA enlargement, septal E/e' ratio ≥11 and AF duration >90 days predicted AF recurrence at 3 months.
No takes yet. Share an insight, caveat, or question.
Fornengo et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: